Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EXC vs MRNA✓SelectedUSD · MRNAEXC vs MRNA performance historyLatest closeAs of-1.29%11/17
Stock and ETF performance explorer

EXC vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+6.3%
MRNA return
+313.8%
Excess return
-307.5%
Maximum drawdown
-15.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.3%-3.9%+2.6%-1.3%
7D+0.7%-17.6%+18.3%+0.6%
30D+5.4%-5.1%+10.6%+5.4%
3M+1.6%+220.8%-219.2%+1.9%
All+6.3%+313.8%-307.5%+10.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling